BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali ES, Rajapaksha H, Carr JM, Petrovsky N. Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens. Antiviral Res 2016;133:14-22. [PMID: 27421712 DOI: 10.1016/j.antiviral.2016.07.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Santos-Ferreira N, Van Dycke J, Neyts J, Rocha-Pereira J. Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections. Microorganisms 2021;9:1599. [PMID: 34442677 DOI: 10.3390/microorganisms9081599] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Galasiti Kankanamalage AC, Kim Y, Rathnayake AD, Damalanka VC, Weerawarna PM, Doyle ST, Alsoudi AF, Dissanayake DMP, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC. Structure-based exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design of potent and permeable inhibitors. Eur J Med Chem 2017;126:502-16. [PMID: 27914364 DOI: 10.1016/j.ejmech.2016.11.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
3 Tan MTH, Li Y, Eshaghi Gorji M, Gong Z, Li D. Fucoidan But Not 2'-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae. Viruses 2021;13:461. [PMID: 33799811 DOI: 10.3390/v13030461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Heggelund JE, Varrot A, Imberty A, Krengel U. Histo-blood group antigens as mediators of infections. Curr Opin Struct Biol 2017;44:190-200. [PMID: 28544984 DOI: 10.1016/j.sbi.2017.04.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
5 Almand EA, Moore MD, Jaykus LA. Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens. Front Microbiol 2017;8:2549. [PMID: 29312233 DOI: 10.3389/fmicb.2017.02549] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
6 Liu J, Wang D. ABO(H) and Lewis blood group substances and disease treatment. Transfus Med 2021. [PMID: 34569102 DOI: 10.1111/tme.12820] [Reference Citation Analysis]
7 Mathez G, Cagno V. Viruses Like Sugars: How to Assess Glycan Involvement in Viral Attachment. Microorganisms 2021;9:1238. [PMID: 34200288 DOI: 10.3390/microorganisms9061238] [Reference Citation Analysis]
8 Zhu Y, Kawai H, Hashiba S, Amarasiri M, Kitajima M, Okabe S, Sano D. The Effect of GD1a Ganglioside-Expressing Bacterial Strains on Murine Norovirus Infectivity. Molecules 2020;25:E4084. [PMID: 32906699 DOI: 10.3390/molecules25184084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]